Keytruda vs Biktarvy
Side-by-side drug price comparison from Medicare Part D data
Verdict
Biktarvy costs 79% less per claim than Keytruda ($3746.00 vs $18176.00). Neither drug has a generic alternative available. Total Medicare spending: Keytruda at $7.2B vs Biktarvy at $3.8B.
| Metric | Keytruda | Biktarvy |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $18,176 | $3,746* |
| Total Medicare Spending Total Medicare Part D spending on this drug | $7.2B | $3.8B |
| Total Claims | 398,000 | 1,020,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 28.6% | 12.8%* |
| Generic Available | No | No |
| Condition | Cancer | HIV |
| Total Beneficiaries | 82,000 | 85,000 |
Biktarvy costs 79% less per claim than Keytruda ($3746.00 vs $18176.00). Neither drug has a generic alternative available. Total Medicare spending: Keytruda at $7.2B vs Biktarvy at $3.8B.